首页 > 最新文献

Applied Biosafety最新文献

英文 中文
A Review of Recent Evidence for Utilizing Ultraviolet Irradiation Technology to Disinfect Both Indoor Air and Surfaces. 利用紫外线照射技术对室内空气和表面进行消毒的最新证据综述。
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2021-03-01 Epub Date: 2021-03-19 DOI: 10.1089/apb.20.0056
Farhad Memarzadeh

Background: The implementation of "no-touch" technologies such as ultraviolet (UV)-based sanitizers to effectively disinfect the air and high-touch surfaces may be important to keeping working environments and indoor public gathering places, where there may be a higher risk of infection from specific agents, safe for all occupants, particularly with the emergence of highly communicable diseases. UV technologies have been used for many years and are being revisited as one of disinfecting technology to address the SARS-CoV-2 virus that causes COVID-19. Methods: We selected over 20 relevant source documents from approximately 80 papers dating between 1985 and the present (2020) to evaluate the applicability, safety and relative contribution of ultraviolet to disinfect air and surfaces in the built environment. UV-based sanitizers have the potential for effective application when used in conjunction with other disinfecting means. Results: The efficacy of UV-based sanitizer technologies are promising but are dependent on numerous environmental, physical and technical factors. Conclusions: We believe that UV technologies should not be utilized in isolation and should be considered as an adjunct to protocol-driven standard operating procedures for cleaning and disinfection, had hygiene practices, and appropriate use of personal protective equipment (PPE).

背景:实施“无接触”技术,如基于紫外线(UV)的消毒剂,对空气和高接触表面进行有效消毒,对于保持工作环境和室内公共聚集场所对所有居住者的安全可能很重要,因为这些地方可能有较高的感染特定物的风险,特别是在高度传染性疾病出现的情况下。紫外线技术已经使用多年,现在正被重新考虑作为消毒技术之一,以应对导致COVID-19的SARS-CoV-2病毒。方法:从1985年至今(2020年)的约80篇论文中选择20多篇相关源文件,评估紫外线在建筑环境中消毒空气和表面的适用性、安全性和相对贡献。当与其他消毒手段结合使用时,基于紫外线的消毒剂具有有效应用的潜力。结果:基于紫外线的消毒液技术的效果是有前景的,但依赖于许多环境、物理和技术因素。结论:我们认为紫外线技术不应该孤立地使用,而应该被视为协议驱动的标准操作程序的辅助,用于清洁和消毒,有卫生习惯,并适当使用个人防护装备(PPE)。
{"title":"A Review of Recent Evidence for Utilizing Ultraviolet Irradiation Technology to Disinfect Both Indoor Air and Surfaces.","authors":"Farhad Memarzadeh","doi":"10.1089/apb.20.0056","DOIUrl":"https://doi.org/10.1089/apb.20.0056","url":null,"abstract":"<p><p><b>Background:</b> The implementation of \"no-touch\" technologies such as ultraviolet (UV)-based sanitizers to effectively disinfect the air and high-touch surfaces may be important to keeping working environments and indoor public gathering places, where there may be a higher risk of infection from specific agents, safe for all occupants, particularly with the emergence of highly communicable diseases. UV technologies have been used for many years and are being revisited as one of disinfecting technology to address the SARS-CoV-2 virus that causes COVID-19. <b>Methods:</b> We selected over 20 relevant source documents from approximately 80 papers dating between 1985 and the present (2020) to evaluate the applicability, safety and relative contribution of ultraviolet to disinfect air and surfaces in the built environment. UV-based sanitizers have the potential for effective application when used in conjunction with other disinfecting means. <b>Results:</b> The efficacy of UV-based sanitizer technologies are promising but are dependent on numerous environmental, physical and technical factors. <b>Conclusions:</b> We believe that UV technologies should not be utilized in isolation and should be considered as an adjunct to protocol-driven standard operating procedures for cleaning and disinfection, had hygiene practices, and appropriate use of personal protective equipment (PPE).</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"26 1","pages":"52-56"},"PeriodicalIF":1.5,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869636/pdf/apb.20.0056.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33443246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Applied Biosafety's Themed Issue on Decontamination Methods and Emerging Technologies 应用生物安全专题:去污方法和新兴技术
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2021-03-01 DOI: 10.1089/APB.2021.28999.BJO
Barbara Johnson, K. Byers, S. Patlovich, David R Gillum
{"title":"Applied Biosafety's Themed Issue on Decontamination Methods and Emerging Technologies","authors":"Barbara Johnson, K. Byers, S. Patlovich, David R Gillum","doi":"10.1089/APB.2021.28999.BJO","DOIUrl":"https://doi.org/10.1089/APB.2021.28999.BJO","url":null,"abstract":"","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"26 1","pages":"1-1"},"PeriodicalIF":1.5,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44131278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Use of Sea Water as a Diluent for an Accelerated Hydrogen Peroxide Disinfectant for Inactivation of Avian Influenza Virus: A Surrogate for Infectious Salmon Anemia Virus. 用海水作为加速过氧化氢消毒液灭活禽流感病毒的稀释剂的评价:传染性鲑鱼贫血病毒的替代品。
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2021-03-01 Epub Date: 2021-03-19 DOI: 10.1089/apb.20.0054
Jiewen Guan, Maria Chan, Brian W Brooks, Elizabeth Rohonczy

Introduction: Use of sea water as a diluent for disinfectants has been of practical interest for control of aquaculture disease outbreaks in sea where fresh water is limited. This study evaluated the use of natural sea water (NSW), artificial sea water (ASW), or standard hard water (SHW) as a diluent for preparation of accelerated hydrogen peroxide (AHP) solutions against an avian influenza virus, a surrogate for the infectious salmon anemia virus. Methods: AHP solutions containing 0.18%, 0.35%, or 0.44% (w/w) of hydrogen peroxide (H2O2), corresponding to 1/40, 1/20, and 1/16 dilutions of the disinfectant concentrate, were evaluated at -20°C, 4°C, and 21°C. Results: When NSW was used as the diluent, a 0.35% H2O2 concentration was required to inactivate ∼6 log10 virus at 21°C in a 5-min contact time. When temperature dropped to 4°C, 0.44% H2O2 in NSW was required to obtain a similar inactivation within a 5-min contact time. At -20°C, supplemented with antifreeze agents, the 0.44% H2O2 in NSW solutions produced complete inactivation of 5.4 log10 virus within a 10-min contact time. In comparison, lower H2O2 concentrations and/or shorter contact times were needed to inactivate equal amounts of the virus at the same temperature when using SHW or ASW as a diluent to prepare disinfection solutions. Conclusion: The results suggested that NSW could be used as a diluent in disinfection solutions for virus inactivation as long as disinfectant concentrations and/or contact times are properly increased.

前言:利用海水作为消毒剂的稀释剂对于控制淡水有限的海洋中水产养殖疾病暴发具有实际意义。本研究评估了使用天然海水(NSW)、人工海水(ASW)或标准硬水(SHW)作为稀释剂制备抗禽流感病毒(传染性鲑鱼贫血病毒的替代品)的加速过氧化氢(AHP)溶液。方法:在-20°C、4°C和21°C条件下,分别对含有0.18%、0.35%或0.44% (w/w)过氧化氢(H2O2)的AHP溶液,分别进行1/40、1/20和1/16稀释度的消毒浓缩液进行评价。结果:当使用NSW作为稀释液时,需要0.35%的H2O2浓度在21°C下在5分钟接触时间内灭活~ 6 log10病毒。当温度降至4°C时,需要0.44%的H2O2在NSW中,在5分钟的接触时间内获得类似的失活效果。在-20°C条件下,加入抗冻剂,0.44% H2O2的NSW溶液在10分钟的接触时间内完全灭活了5.4 log10病毒。相比之下,当使用SHW或ASW作为稀释剂制备消毒溶液时,在相同温度下,需要更低的H2O2浓度和/或更短的接触时间来灭活等量的病毒。结论:只要适当增加消毒剂浓度和接触次数,NSW可作为消毒液的稀释剂灭活病毒。
{"title":"Evaluation of the Use of Sea Water as a Diluent for an Accelerated Hydrogen Peroxide Disinfectant for Inactivation of Avian Influenza Virus: A Surrogate for Infectious Salmon Anemia Virus.","authors":"Jiewen Guan,&nbsp;Maria Chan,&nbsp;Brian W Brooks,&nbsp;Elizabeth Rohonczy","doi":"10.1089/apb.20.0054","DOIUrl":"https://doi.org/10.1089/apb.20.0054","url":null,"abstract":"<p><p><b>Introduction:</b> Use of sea water as a diluent for disinfectants has been of practical interest for control of aquaculture disease outbreaks in sea where fresh water is limited. This study evaluated the use of natural sea water (NSW), artificial sea water (ASW), or standard hard water (SHW) as a diluent for preparation of accelerated hydrogen peroxide (AHP) solutions against an avian influenza virus, a surrogate for the infectious salmon anemia virus. <b>Methods:</b> AHP solutions containing 0.18%, 0.35%, or 0.44% (w/w) of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), corresponding to 1/40, 1/20, and 1/16 dilutions of the disinfectant concentrate, were evaluated at -20°C, 4°C, and 21°C. <b>Results:</b> When NSW was used as the diluent, a 0.35% H<sub>2</sub>O<sub>2</sub> concentration was required to inactivate ∼6 log<sub>10</sub> virus at 21°C in a 5-min contact time. When temperature dropped to 4°C, 0.44% H<sub>2</sub>O<sub>2</sub> in NSW was required to obtain a similar inactivation within a 5-min contact time. At -20°C, supplemented with antifreeze agents, the 0.44% H<sub>2</sub>O<sub>2</sub> in NSW solutions produced complete inactivation of 5.4 log<sub>10</sub> virus within a 10-min contact time. In comparison, lower H<sub>2</sub>O<sub>2</sub> concentrations and/or shorter contact times were needed to inactivate equal amounts of the virus at the same temperature when using SHW or ASW as a diluent to prepare disinfection solutions. <b>Conclusion:</b> The results suggested that NSW could be used as a diluent in disinfection solutions for virus inactivation as long as disinfectant concentrations and/or contact times are properly increased.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"26 1","pages":"2-5"},"PeriodicalIF":1.5,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869627/pdf/apb.20.0054.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33442787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safeguards for Using Viral Vector Systems in Human Gene Therapy: A Resource for Biosafety Professionals Mitigating Risks in Health Care Settings. 在人类基因治疗中使用病毒载体系统的保障措施:生物安全专业人员在卫生保健环境中降低风险的资源。
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2020-12-01 DOI: 10.1177/1535676020934917
Alex M Brown, Jill Blind, Katie Campbell, Sumit Ghosh
<p><strong>Introduction: </strong>Health care workers who work daily with human body fluids and hazardous drugs are among those at the highest risk of occupational exposure to these agents. The Occupational Safety and Health Administration's (OSHA) Bloodborne Pathogens Standard (29 CFR 1910.1030) prescribes safeguards to protect workers against health hazards related to bloodborne pathogens. Similarly, the United States Pharmacopeia General Chapter 800 (USP <800>), a standard first published in February 2016 and implementation required by December 2019, addresses the occupational exposure risks of health care workers at organizations working with hazardous drugs. With emerging technologies in the field of gene therapy, these occupational exposure risks to health care workers now extend beyond those associated with bloodborne pathogens and hazardous drugs and now include recombinant DNA. The fifth edition of the <i>Biosafety in Microbiological and Biomedical Laboratories</i> (<i>BMBL</i>) and the National Institutes of Health Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) mostly govern work with biohazardous agents and recombinant DNA in a laboratory research setting. When gene therapy products are utilized in a hospital environment, health care workers have very few resources to identify and reduce the risks associated with product use during and after the administration of treatments.</p><p><strong>Methods: </strong>At the Abigail Wexner Research Institute at Nationwide Children's Hospital, a comprehensive gap analysis was executed between the research and health care environment to develop a program for risk mitigation. The <i>BMBL</i>, NIH Guidelines, World Health Organization Biosafety Manual, OSHA Bloodborne Pathogens Standard, and USP <800> were used to develop a framework for the gap analysis process.</p><p><strong>Results: </strong>The standards and guidelines for working with viral vector systems in a research laboratory environment were adapted to develop a program that will mitigate the risks to health care workers involved in the preparation, transportation, and administration of gene therapies as well as subsequent patient care activities. The gap analysis identified significant differences in technical language used in daily operations, work environment, training and education, disinfection practices, and policy development between research and health care settings. These differences informed decisions and helped the organization develop a collaborative framework for risk mitigation when a gene therapy product enters the health care setting.</p><p><strong>Discussion: </strong>With continuing advances in the field of gene therapy, the oversight structure needs to evolve for the health care setting. To deliver the best outcomes to the patients of these therapies, researchers, Institutional Biosafety Committees, and health care workers need to collaborate on training programs to safeg
导言:每天与人体体液和危险药物打交道的卫生保健工作者是职业接触这些物质风险最高的人群之一。职业安全与健康管理局(OSHA)血源性病原体标准(29 CFR 1910.1030)规定了保护工人免受与血源性病原体有关的健康危害的保障措施。同样,美国药典通章800 (USP)于2016年2月首次发布,并要求于2019年12月实施,该标准解决了从事危险药物工作的组织中的卫生保健工作者的职业暴露风险。随着基因治疗领域的新兴技术,卫生保健工作者面临的这些职业暴露风险现已超出与血源性病原体和危险药物相关的风险,现在还包括重组DNA。《微生物和生物医学实验室的生物安全》(BMBL)第五版和《国立卫生研究院涉及重组或合成核酸分子的研究指南》(NIH指南)主要管理在实验室研究环境中使用生物危险剂和重组DNA的工作。当在医院环境中使用基因治疗产品时,卫生保健工作者几乎没有资源来识别和减少与治疗期间和治疗后使用产品相关的风险。方法:在全国儿童医院的Abigail Wexner研究所,对研究与卫生保健环境进行了全面的差距分析,以制定风险缓解方案。使用BMBL、NIH指南、世界卫生组织生物安全手册、OSHA血源性病原体标准和USP来开发差距分析过程的框架。结果:在研究实验室环境中使用病毒载体系统的标准和指南进行了调整,以制定一项计划,以减轻参与基因治疗的准备、运输和管理以及随后的患者护理活动的卫生保健工作者的风险。差距分析确定了研究和卫生保健机构之间在日常操作、工作环境、培训和教育、消毒做法和政策制定中使用的技术语言的重大差异。这些差异为决策提供了依据,并帮助该组织在基因治疗产品进入卫生保健环境时制定了降低风险的协作框架。讨论:随着基因治疗领域的不断进步,卫生保健机构的监督结构需要发展。为了给患者提供这些疗法的最佳结果,研究人员、机构生物安全委员会和卫生保健工作者需要在培训项目上进行合作,以保障公众对这项技术在临床试验和fda批准的治疗方法中的使用的信任。
{"title":"Safeguards for Using Viral Vector Systems in Human Gene Therapy: A Resource for Biosafety Professionals Mitigating Risks in Health Care Settings.","authors":"Alex M Brown,&nbsp;Jill Blind,&nbsp;Katie Campbell,&nbsp;Sumit Ghosh","doi":"10.1177/1535676020934917","DOIUrl":"https://doi.org/10.1177/1535676020934917","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Health care workers who work daily with human body fluids and hazardous drugs are among those at the highest risk of occupational exposure to these agents. The Occupational Safety and Health Administration's (OSHA) Bloodborne Pathogens Standard (29 CFR 1910.1030) prescribes safeguards to protect workers against health hazards related to bloodborne pathogens. Similarly, the United States Pharmacopeia General Chapter 800 (USP &lt;800&gt;), a standard first published in February 2016 and implementation required by December 2019, addresses the occupational exposure risks of health care workers at organizations working with hazardous drugs. With emerging technologies in the field of gene therapy, these occupational exposure risks to health care workers now extend beyond those associated with bloodborne pathogens and hazardous drugs and now include recombinant DNA. The fifth edition of the &lt;i&gt;Biosafety in Microbiological and Biomedical Laboratories&lt;/i&gt; (&lt;i&gt;BMBL&lt;/i&gt;) and the National Institutes of Health Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) mostly govern work with biohazardous agents and recombinant DNA in a laboratory research setting. When gene therapy products are utilized in a hospital environment, health care workers have very few resources to identify and reduce the risks associated with product use during and after the administration of treatments.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;At the Abigail Wexner Research Institute at Nationwide Children's Hospital, a comprehensive gap analysis was executed between the research and health care environment to develop a program for risk mitigation. The &lt;i&gt;BMBL&lt;/i&gt;, NIH Guidelines, World Health Organization Biosafety Manual, OSHA Bloodborne Pathogens Standard, and USP &lt;800&gt; were used to develop a framework for the gap analysis process.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The standards and guidelines for working with viral vector systems in a research laboratory environment were adapted to develop a program that will mitigate the risks to health care workers involved in the preparation, transportation, and administration of gene therapies as well as subsequent patient care activities. The gap analysis identified significant differences in technical language used in daily operations, work environment, training and education, disinfection practices, and policy development between research and health care settings. These differences informed decisions and helped the organization develop a collaborative framework for risk mitigation when a gene therapy product enters the health care setting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;With continuing advances in the field of gene therapy, the oversight structure needs to evolve for the health care setting. To deliver the best outcomes to the patients of these therapies, researchers, Institutional Biosafety Committees, and health care workers need to collaborate on training programs to safeg","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"25 4","pages":"184-193"},"PeriodicalIF":1.5,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1535676020934917","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10259659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Assessment of the Biorisk Status of Veterinary Laboratories in Southwest Nigeria: Application of the Food and Agriculture Organization Laboratory Mapping Tool-Safety Module. 尼日利亚西南部兽医实验室生物风险状况评估:应用粮农组织实验室绘图工具-安全模块。
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2020-12-01 DOI: 10.1177/1535676020930130
Oluwawemimo Adebowale, Adebankemo Oduguwa, Saheed Dipeolu, Michael Agbaje, Olubumni Fasanmi, Folorunso Oludayo Fasina

Introduction: Because of the nature of work conducted in veterinary laboratories and potential exposures to pathogenic microorganisms, good laboratory practices, risk assessments, biosafety, and biosecurity capacity is becoming vital. In this study, the Food and Agriculture Organization Laboratory Mapping Tool-Safety Module was applied to demonstrate its practical implementation in the assessment of biosafety and biosecurity statuses of veterinary laboratories in Nigeria.

Methods: The Laboratory Mapping Tool-Safety Module, a standardized questionnaire, systematically and semiquantitatively gathered data on 98 subcategories covering 4 areas of biosafety and biosecurity capabilities: administrative, operational, engineering, and personal protective equipment.

Results: Overall, the various areas and categories covered by the Laboratory Mapping Tool-Safety Module were weak across the board, with a mean performance of 19.5% (95% confidence interval, 14.0%-25.1%; range, 0.8%-29.6%). The weakest functionality was in emergency preparedness (0.8%; ie, emergency responses and exercises such as fire drills, spill cleanup, and biological spill kit availability). Also, many laboratories were deficient in metrology procedures, biosafety cabinets, chemical hazard containment, regular maintenance and external calibration procedures for laboratory equipment, and personnel health and safety. However, a few functionalities within individual laboratories scored above average (50%), for example, a university microbiology laboratory animal facility (100%). Interlaboratory comparison indicated that biosafety and biosecurity performance was similar across laboratories (P = .07) and did not vary by location (P = .37).

Conclusions: Significant biosafety and biosecurity improvements are needed to guarantee the health and safety of workers and the global community, efficient responses to infectious disease containment, and compliance with the Global Health Security Agenda.

导言:由于兽医实验室工作的性质和潜在的病原微生物暴露,良好的实验室规范、风险评估、生物安全和生物安全能力变得至关重要。在本研究中,应用粮农组织实验室绘图工具-安全模块来演示其在尼日利亚兽医实验室生物安全和生物安全状况评估中的实际实施情况。方法:采用标准化问卷“实验室测绘工具-安全模块”,系统和半定量地收集了涉及生物安全和生物安保能力4个领域(行政、操作、工程和个人防护装备)的98个子类别的数据。结果:总体而言,实验室制图工具-安全模块所涵盖的各个领域和类别全面薄弱,平均表现为19.5%(95%置信区间为14.0%-25.1%;范围内,0.8% - -29.6%)。最弱的功能是应急准备(0.8%;例如,应急反应和演习,如消防演习、泄漏清理和生物泄漏工具包的可用性)。此外,许多实验室在计量程序、生物安全柜、化学危害控制、实验室设备的定期维护和外部校准程序以及人员健康和安全方面存在缺陷。然而,个别实验室的一些功能得分高于平均水平(50%),例如,大学微生物实验室动物设施(100%)。实验室间比较表明,不同实验室的生物安全和生物安保绩效相似(P = .07),而不同地点的生物安全和生物安保绩效没有差异(P = .37)。结论:需要显著改善生物安全和生物安全,以保证工人和全球社区的健康和安全,有效应对传染病控制,并遵守全球卫生安全议程。
{"title":"Assessment of the Biorisk Status of Veterinary Laboratories in Southwest Nigeria: Application of the Food and Agriculture Organization Laboratory Mapping Tool-Safety Module.","authors":"Oluwawemimo Adebowale,&nbsp;Adebankemo Oduguwa,&nbsp;Saheed Dipeolu,&nbsp;Michael Agbaje,&nbsp;Olubumni Fasanmi,&nbsp;Folorunso Oludayo Fasina","doi":"10.1177/1535676020930130","DOIUrl":"https://doi.org/10.1177/1535676020930130","url":null,"abstract":"<p><strong>Introduction: </strong>Because of the nature of work conducted in veterinary laboratories and potential exposures to pathogenic microorganisms, good laboratory practices, risk assessments, biosafety, and biosecurity capacity is becoming vital. In this study, the Food and Agriculture Organization Laboratory Mapping Tool-Safety Module was applied to demonstrate its practical implementation in the assessment of biosafety and biosecurity statuses of veterinary laboratories in Nigeria.</p><p><strong>Methods: </strong>The Laboratory Mapping Tool-Safety Module, a standardized questionnaire, systematically and semiquantitatively gathered data on 98 subcategories covering 4 areas of biosafety and biosecurity capabilities: administrative, operational, engineering, and personal protective equipment.</p><p><strong>Results: </strong>Overall, the various areas and categories covered by the Laboratory Mapping Tool-Safety Module were weak across the board, with a mean performance of 19.5% (95% confidence interval, 14.0%-25.1%; range, 0.8%-29.6%). The weakest functionality was in emergency preparedness (0.8%; ie, emergency responses and exercises such as fire drills, spill cleanup, and biological spill kit availability). Also, many laboratories were deficient in metrology procedures, biosafety cabinets, chemical hazard containment, regular maintenance and external calibration procedures for laboratory equipment, and personnel health and safety. However, a few functionalities within individual laboratories scored above average (50%), for example, a university microbiology laboratory animal facility (100%). Interlaboratory comparison indicated that biosafety and biosecurity performance was similar across laboratories (<i>P</i> = .07) and did not vary by location (<i>P</i> = .37).</p><p><strong>Conclusions: </strong>Significant biosafety and biosecurity improvements are needed to guarantee the health and safety of workers and the global community, efficient responses to infectious disease containment, and compliance with the Global Health Security Agenda.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"25 4","pages":"232-239"},"PeriodicalIF":1.5,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1535676020930130","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10254351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Multicycle Autoclave Decontamination of N95 Filtering Facepiece Respirators. N95过滤式口罩的多循环高压灭菌净化。
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2020-09-01 DOI: 10.1177/1535676020924171
Nathen E Bopp, Donald H Bouyer, Christopher M Gibbs, Joan E Nichols, Corrie A Ntiforo, Miguel A Grimaldo

Introduction: During pandemic situations like the one caused by the emergent coronavirus SARS-CoV-2, healthcare systems face the challenge of limited personal protective equipment and impaired supply chains. This problem poses a threat to healthcare workers, first responders, and the public, which demands solutions that can span the gap between institutional shortages and resupplies.

Objectives: To examine the efficacy of autoclave-based decontamination for the reuse of single-use surgical masks and N95 filtering facepiece respirators (FFRs). This method is the most readily available form of decontamination in the hospital and laboratory settings.

Methods: Three models of N95 FFRs and two procedural masks were evaluated in this study. A moist heat autoclave using four different autoclave cycles: 115°C for one hour, 121.1°C for 30 minutes, 130°C for two minutes, and 130°C for four minutes was used. After the autoclave process, the FFRs were NIOSH fit tested and particle counting was performed for both coarse particles of 5 micrometers (µM) and fine particles from 0.1µM to 1.0µM.

Results: We observed negligible alterations in the functionality and integrity of 3M 1805 and 3M 1870/1870+ N95 FFRs after three autoclave cycles. Surgical masks also showed minimal changes in functionality and integrity. The 3M 1860 FFR failed fit test after a single autoclave decontamination cycle.

Discussion and conclusion: The study finds that specific surgical masks and N95 FFR models can withstand autoclave decontamination for up to three cycles. Additionally, the autoclave cycles tested were those that could be readily achieved by both clinical and research institutions.

在SARS-CoV-2等突发冠状病毒引起的大流行情况下,卫生保健系统面临着个人防护装备有限和供应链受损的挑战。这一问题对卫生保健工作者、急救人员和公众构成威胁,因此需要能够弥补机构短缺和再补给之间差距的解决方案。目的:探讨高压灭菌对一次性医用口罩和N95过滤式口罩(FFRs)重复使用的消毒效果。这种方法是医院和实验室环境中最容易获得的净化形式。方法:对3种N95型ffr和2种程序性口罩进行评价。使用四种不同循环的湿热高压灭菌器:115°C 1小时,121.1°C 30分钟,130°C 2分钟,130°C 4分钟。经过高压灭菌处理后,对ffr进行NIOSH贴合测试,并对5微米(µM)的粗颗粒和0.1µM至1.0µM的细颗粒进行颗粒计数。结果:经过三次高压灭菌循环后,我们观察到3M 1805和3M 1870/1870+ N95 ffr的功能和完整性发生了可忽略不计的变化。医用口罩在功能和完整性方面也显示出很小的变化。3M 1860 FFR在一次高压灭菌器净化循环后未能通过配合测试。讨论和结论:研究发现,特定的外科口罩和N95 FFR型号可以承受高达三个周期的高压灭菌消毒。此外,测试的高压灭菌器循环是那些可以很容易地实现临床和研究机构。
{"title":"Multicycle Autoclave Decontamination of N95 Filtering Facepiece Respirators.","authors":"Nathen E Bopp,&nbsp;Donald H Bouyer,&nbsp;Christopher M Gibbs,&nbsp;Joan E Nichols,&nbsp;Corrie A Ntiforo,&nbsp;Miguel A Grimaldo","doi":"10.1177/1535676020924171","DOIUrl":"https://doi.org/10.1177/1535676020924171","url":null,"abstract":"<p><strong>Introduction: </strong>During pandemic situations like the one caused by the emergent coronavirus SARS-CoV-2, healthcare systems face the challenge of limited personal protective equipment and impaired supply chains. This problem poses a threat to healthcare workers, first responders, and the public, which demands solutions that can span the gap between institutional shortages and resupplies.</p><p><strong>Objectives: </strong>To examine the efficacy of autoclave-based decontamination for the reuse of single-use surgical masks and N95 filtering facepiece respirators (FFRs). This method is the most readily available form of decontamination in the hospital and laboratory settings.</p><p><strong>Methods: </strong>Three models of N95 FFRs and two procedural masks were evaluated in this study. A moist heat autoclave using four different autoclave cycles: 115°C for one hour, 121.1°C for 30 minutes, 130°C for two minutes, and 130°C for four minutes was used. After the autoclave process, the FFRs were NIOSH fit tested and particle counting was performed for both coarse particles of 5 micrometers (µM) and fine particles from 0.1µM to 1.0µM.</p><p><strong>Results: </strong>We observed negligible alterations in the functionality and integrity of 3M 1805 and 3M 1870/1870+ N95 FFRs after three autoclave cycles. Surgical masks also showed minimal changes in functionality and integrity. The 3M 1860 FFR failed fit test after a single autoclave decontamination cycle.</p><p><strong>Discussion and conclusion: </strong>The study finds that specific surgical masks and N95 FFR models can withstand autoclave decontamination for up to three cycles. Additionally, the autoclave cycles tested were those that could be readily achieved by both clinical and research institutions.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"25 3","pages":"150-156"},"PeriodicalIF":1.5,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1535676020924171","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10622007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
In Vitro Inactivation of SARS-CoV-2 Using Gamma Radiation. 伽玛辐射体外灭活SARS-CoV-2的研究
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2020-09-01 DOI: 10.1177/1535676020934242
Anders Leung, Kaylie Tran, Jonathan Audet, Sherisse Lavineway, Nathalie Bastien, Jay Krishnan

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is classified as a Risk Group 3 pathogen; propagative work with this live virus should be conducted in biosafety level-3 (BSL-3) laboratories. However, inactivated virus can be safely handled in BSL-2 laboratories. Gamma irradiation is one of the methods used to inactivate a variety of pathogens including viruses.

Objective: To determine the radiation dose required to inactivate SARS-CoV-2 and its effect, if any, on subsequent polymerase chain reaction (PCR) assay.

Methods: Aliquots of SARS-CoV-2 virus culture were subjected to increasing doses of gamma radiation to determine the proper dose required to inactivate the virus. Real-time quantitative polymerase chain reaction (RT-qPCR) data from irradiated samples was compared with that of the non-irradiated samples to assess the effect of gamma radiation on PCR assay.

Results: A radiation dose of 1 Mrad was required to completely inactivate 106.5 TCID50/ml of SARS-CoV-2. The influence of gamma radiation on PCR sensitivity was inversely related and dose-dependent up to 0.5 Mrad with no further reduction thereafter.

Conclusion: Gamma irradiation can be used as a reliable method to inactivate SARS-CoV-2 with minimal effect on subsequent PCR assay.

简介:严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)被列为危险组3;这种活病毒的繁殖工作应在生物安全3级(BSL-3)实验室进行。然而,灭活病毒可以在生物安全二级实验室安全地处理。射线照射是用来灭活包括病毒在内的多种病原体的方法之一。目的:确定灭活SARS-CoV-2所需的辐射剂量及其对随后的聚合酶链反应(PCR)试验的影响(如果有的话)。方法:将等量的SARS-CoV-2病毒培养物进行增加剂量的伽马辐射,以确定灭活病毒所需的适当剂量。将辐照样品的实时定量聚合酶链反应(RT-qPCR)数据与未辐照样品的实时定量聚合酶链反应(RT-qPCR)数据进行比较,以评估伽马辐射对PCR检测的影响。结果:1 Mrad的辐射剂量可完全灭活106.5 TCID50/ml的SARS-CoV-2。γ辐射对PCR敏感性的影响呈负相关且剂量依赖性,最高可达0.5 Mrad,此后没有进一步降低。结论:伽玛辐照可作为一种可靠的灭活SARS-CoV-2的方法,对后续PCR检测影响最小。
{"title":"In Vitro Inactivation of SARS-CoV-2 Using Gamma Radiation.","authors":"Anders Leung,&nbsp;Kaylie Tran,&nbsp;Jonathan Audet,&nbsp;Sherisse Lavineway,&nbsp;Nathalie Bastien,&nbsp;Jay Krishnan","doi":"10.1177/1535676020934242","DOIUrl":"https://doi.org/10.1177/1535676020934242","url":null,"abstract":"<p><strong>Introduction: </strong>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is classified as a Risk Group 3 pathogen; propagative work with this live virus should be conducted in biosafety level-3 (BSL-3) laboratories. However, inactivated virus can be safely handled in BSL-2 laboratories. Gamma irradiation is one of the methods used to inactivate a variety of pathogens including viruses.</p><p><strong>Objective: </strong>To determine the radiation dose required to inactivate SARS-CoV-2 and its effect, if any, on subsequent polymerase chain reaction (PCR) assay.</p><p><strong>Methods: </strong>Aliquots of SARS-CoV-2 virus culture were subjected to increasing doses of gamma radiation to determine the proper dose required to inactivate the virus. Real-time quantitative polymerase chain reaction (RT-qPCR) data from irradiated samples was compared with that of the non-irradiated samples to assess the effect of gamma radiation on PCR assay.</p><p><strong>Results: </strong>A radiation dose of 1 Mrad was required to completely inactivate 10<sup>6.5</sup> TCID<sub>50</sub>/ml of SARS-CoV-2. The influence of gamma radiation on PCR sensitivity was inversely related and dose-dependent up to 0.5 Mrad with no further reduction thereafter.</p><p><strong>Conclusion: </strong>Gamma irradiation can be used as a reliable method to inactivate SARS-CoV-2 with minimal effect on subsequent PCR assay.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"25 3","pages":"157-160"},"PeriodicalIF":1.5,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1535676020934242","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10622008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Determining the Effectiveness of Decontamination with Ionized Hydrogen Peroxide. 测定电离过氧化氢去污效果。
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2020-09-01 DOI: 10.1177/1535676020935405
Miguel A Grimaldo, Donald H Bouyer, Claudio L Mafra de Siqueira

Introduction: Ionized Hydrogen Peroxide (iHP) is a new technology used for the decontamination of surfaces or laboratory areas. It utilizes a low concentration of hydrogen peroxide (H2O2) mixed with air and ionized through a cold plasma arc. This technology generates reactive oxygen species (ROS) as a means of decontamination.

Objectives: The purpose of this study is to evaluate the diffusion effect of iHP and its decontamination capabilities using biological and enzyme indicators.

Methods: A gas-tight fumigation room with a volume of 880 ft3 was used for the decontamination trials. During the decontamination process, empty animal cages were placed inside to create fumigant distribution restrictions. Spore and enzyme indicators were placed in eleven locations throughout the decontamination room. Generation of iHP was done with the use of TOMI's SteraMist Environmental System and the SteraMist Solution, with 7.8% H2O2 at a dose of 0.5 ml per ft3.

Results: For the decontamination of 1hr, 2hrs, 6hrs, and 12hrs, the biological indicators of B. atrophaeus in Stainless Steel (SS) Disk in Tyvek envelope have an inactivation rate of 94%, 97%, 100%, and 100%, respectively. For G. stearothermophilus in SS disk and Tyvek envelope, it has 82%, 68%, 100%, and 100%, respectively and, for G. stearothermophilus in SS strips it has an effective rate of 88%, 67%, 91%, and 100%, respectively.

Conclusion: iHP inactivates spores, and the residual tAK activity indicates a gas-like fumigant diffusion due to the uniformity of the inactivation without the use of oscillating fans as the contact time is extended.

简介:离子化过氧化氢(iHP)是一种用于表面或实验室区域净化的新技术。它利用低浓度的过氧化氢(H2O2)与空气混合,并通过冷等离子弧电离。该技术产生活性氧(ROS)作为净化的手段。目的:利用生物和酶指标评价iHP的扩散效果及其去污能力。方法:采用880ft3的气密熏蒸室进行净化试验。在去污过程中,放置了空的动物笼子,以限制熏蒸剂的分发。孢子和酶指示器被放置在整个净化室的11个位置。iHP的生成使用TOMI的SteraMist环境系统和SteraMist溶液,其中含有7.8%的H2O2,剂量为0.5 ml / ft3。结果:对Tyvek包膜不锈钢(SS)盘片进行1h、2h、6h、12h的去污处理,其生物指标的失活率分别为94%、97%、100%、100%。对于SS磁盘和Tyvek包膜中的嗜热G.,其有效率分别为82%、68%、100%和100%;对于SS条中的嗜热G.,其有效率分别为88%、67%、91%和100%。结论:iHP灭活了孢子,残余tAK活性表明,随着接触时间的延长,由于灭活的均匀性,不使用振荡风扇,熏蒸剂的扩散呈气体状。
{"title":"Determining the Effectiveness of Decontamination with Ionized Hydrogen Peroxide.","authors":"Miguel A Grimaldo,&nbsp;Donald H Bouyer,&nbsp;Claudio L Mafra de Siqueira","doi":"10.1177/1535676020935405","DOIUrl":"https://doi.org/10.1177/1535676020935405","url":null,"abstract":"<p><strong>Introduction: </strong>Ionized Hydrogen Peroxide (iHP) is a new technology used for the decontamination of surfaces or laboratory areas. It utilizes a low concentration of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) mixed with air and ionized through a cold plasma arc. This technology generates reactive oxygen species (ROS) as a means of decontamination.</p><p><strong>Objectives: </strong>The purpose of this study is to evaluate the diffusion effect of iHP and its decontamination capabilities using biological and enzyme indicators.</p><p><strong>Methods: </strong>A gas-tight fumigation room with a volume of 880 ft<sup>3</sup> was used for the decontamination trials. During the decontamination process, empty animal cages were placed inside to create fumigant distribution restrictions. Spore and enzyme indicators were placed in eleven locations throughout the decontamination room. Generation of iHP was done with the use of TOMI's SteraMist Environmental System and the SteraMist Solution, with 7.8% H<sub>2</sub>O<sub>2</sub> at a dose of 0.5 ml per ft<sup>3</sup>.</p><p><strong>Results: </strong>For the decontamination of 1hr, 2hrs, 6hrs, and 12hrs, the biological indicators of <i>B. atrophaeus</i> in Stainless Steel (SS) Disk in Tyvek envelope have an inactivation rate of 94%, 97%, 100%, and 100%, respectively. For <i>G</i>. <i>stearothermophilus</i> in SS disk and Tyvek envelope, it has 82%, 68%, 100%, and 100%, respectively and, for <i>G</i>. <i>stearothermophilus</i> in SS strips it has an effective rate of 88%, 67%, 91%, and 100%, respectively.</p><p><strong>Conclusion: </strong>iHP inactivates spores, and the residual tAK activity indicates a gas-like fumigant diffusion due to the uniformity of the inactivation without the use of oscillating fans as the contact time is extended.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"25 3","pages":"134-141"},"PeriodicalIF":1.5,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1535676020935405","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10310667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rapidly Deployable Test Suite for Respiratory Protective Devices in the COVID-19 Pandemic. COVID-19大流行期间呼吸防护装置快速部署测试套件
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2020-09-01 DOI: 10.1177/1535676020947284
Thijs Blad, Joep Nijssen, Freek Broeren, Bob Boogaard, Stefan Lampaert, Stefan van den Toorn, John van den Dobbelsteen

Introduction: The current COVID-19 pandemic has caused large shortages in personal protective equipment, leading to hospitals buying their supplies from alternative suppliers or even reusing single-use items. Equipment from these alternative sources first needs to be tested to ensure that they properly protect the clinicians that depend on them. This work demonstrates a test suite for protective face masks that can be realized rapidly and cost effectively, using mainly off-the-shelf as well as 3D printing components.

Materials and methods: The proposed test suite was designed and evaluated in order to assess its safety and proper functioning according to the criteria that are stated in the European standard norm EN149:2001+A1 7. These include a breathing resistance test, a CO2 build-up test, and a penetration test. Measurements were performed for a variety of commercially available protective face masks for validation.

Results: The results obtained with the rapidly deployable test suite agree with conventional test methods, demonstrating that this setup can be used to assess the filtering properties of protective masks when conventional equipment is not available.

Discussion: The presented test suite can serve as a starting point for the rapid deployment of more testing facilities for respiratory protective equipment. This could greatly increase the testing capacity and ultimately improve the safety of healthcare workers battling the COVID-19 pandemic.

导语:当前的COVID-19大流行造成个人防护装备严重短缺,导致医院从替代供应商那里购买用品,甚至重复使用一次性用品。首先需要对这些替代来源的设备进行测试,以确保它们能够适当地保护依赖它们的临床医生。这项工作展示了一个防护口罩的测试套件,可以快速和经济有效地实现,主要使用现成的以及3D打印组件。材料和方法:根据欧洲标准规范EN149:2001+A1 7中规定的标准,设计和评估了拟议的测试套件,以评估其安全性和正常功能。这些测试包括呼吸阻力测试、二氧化碳积聚测试和渗透测试。对各种市售防护口罩进行了测量以进行验证。结果:快速部署测试套件获得的结果与常规测试方法一致,表明该设置可用于在常规设备不可用时评估防护口罩的过滤性能。讨论:提出的测试套件可以作为快速部署更多呼吸防护设备测试设施的起点。这将大大提高检测能力,并最终提高医护人员与COVID-19大流行作斗争的安全性。
{"title":"A Rapidly Deployable Test Suite for Respiratory Protective Devices in the COVID-19 Pandemic.","authors":"Thijs Blad,&nbsp;Joep Nijssen,&nbsp;Freek Broeren,&nbsp;Bob Boogaard,&nbsp;Stefan Lampaert,&nbsp;Stefan van den Toorn,&nbsp;John van den Dobbelsteen","doi":"10.1177/1535676020947284","DOIUrl":"https://doi.org/10.1177/1535676020947284","url":null,"abstract":"<p><strong>Introduction: </strong>The current COVID-19 pandemic has caused large shortages in personal protective equipment, leading to hospitals buying their supplies from alternative suppliers or even reusing single-use items. Equipment from these alternative sources first needs to be tested to ensure that they properly protect the clinicians that depend on them. This work demonstrates a test suite for protective face masks that can be realized rapidly and cost effectively, using mainly off-the-shelf as well as 3D printing components.</p><p><strong>Materials and methods: </strong>The proposed test suite was designed and evaluated in order to assess its safety and proper functioning according to the criteria that are stated in the European standard norm EN149:2001+A1 7. These include a breathing resistance test, a CO<sub>2</sub> build-up test, and a penetration test. Measurements were performed for a variety of commercially available protective face masks for validation.</p><p><strong>Results: </strong>The results obtained with the rapidly deployable test suite agree with conventional test methods, demonstrating that this setup can be used to assess the filtering properties of protective masks when conventional equipment is not available.</p><p><strong>Discussion: </strong>The presented test suite can serve as a starting point for the rapid deployment of more testing facilities for respiratory protective equipment. This could greatly increase the testing capacity and ultimately improve the safety of healthcare workers battling the COVID-19 pandemic.</p>","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"25 3","pages":"161-168"},"PeriodicalIF":1.5,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1535676020947284","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10248592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Biological Validation of a Chemical Effluent Decontamination System. 化学污水净化系统的生物验证。
IF 1.5 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2020-07-09 DOI: 10.1177/1535676020937967
C. Cote, J. Weidner, C. Klimko, Ashley E. Piper, Jeremy A Miller, M. Hunter, J. Shoe, J. Hoover, Brian R. Sauerbry, T. Buhr, J. Bozue, David E. Harbourt, Pamela J. Glass
Introduction: Failure of an existing effluent decontamination system (EDS) prompted the consideration of commercial off-the-shelf solutions for decontamination of containment laboratory waste. A bleach-based chemical EDS was purchased to serve as an interim solution. Methods: Studies were conducted in the laboratory to validate inactivation of Bacillus spores with bleach in complex matrices containing organic simulants including fetal bovine serum, humic acid, and animal room sanitation effluent. Results: These studies demonstrated effective decontamination of >106 spores at a free chlorine concentration of ≥5700 parts per million with a 2-hour contact time. Translation of these results to biological validation of the bleach-based chemical EDS required some modifications to the system and its operation. Discussion: The chemical EDS was validated for the treatment of biosafety levels 3 and 4 waste effluent using laboratory-prepared spore packets along with commercial biological indicators; however, several issues and lessons learned identified during the process of onboarding are also discussed, including bleach product source, method of validation, dechlorination, and treated waste disposal.
简介:现有的污水净化系统(EDS)的失败促使考虑商业现成的解决方案,以净化容器实验室废物。购买了一种基于漂白剂的化学物质EDS作为临时解决方案。方法:在实验室进行研究,验证在含有有机模拟物(包括胎牛血清、腐植酸和动物房间卫生污水)的复杂基质中使用漂白剂灭活芽孢杆菌孢子。结果:这些研究表明,游离氯浓度≥5700 ppm,接触时间为2小时,可有效去污>106个孢子。将这些结果转化为基于漂白剂的化学EDS的生物学验证需要对系统及其操作进行一些修改。讨论:利用实验室制备的孢子包和商业生物指示剂,验证了化学EDS处理生物安全等级3和4的废水;然而,也讨论了在入职过程中确定的几个问题和经验教训,包括漂白剂产品来源、验证方法、脱氯和处理后的废物处置。
{"title":"Biological Validation of a Chemical Effluent Decontamination System.","authors":"C. Cote, J. Weidner, C. Klimko, Ashley E. Piper, Jeremy A Miller, M. Hunter, J. Shoe, J. Hoover, Brian R. Sauerbry, T. Buhr, J. Bozue, David E. Harbourt, Pamela J. Glass","doi":"10.1177/1535676020937967","DOIUrl":"https://doi.org/10.1177/1535676020937967","url":null,"abstract":"Introduction: Failure of an existing effluent decontamination system (EDS) prompted the consideration of commercial off-the-shelf solutions for decontamination of containment laboratory waste. A bleach-based chemical EDS was purchased to serve as an interim solution. Methods: Studies were conducted in the laboratory to validate inactivation of Bacillus spores with bleach in complex matrices containing organic simulants including fetal bovine serum, humic acid, and animal room sanitation effluent. Results: These studies demonstrated effective decontamination of >106 spores at a free chlorine concentration of ≥5700 parts per million with a 2-hour contact time. Translation of these results to biological validation of the bleach-based chemical EDS required some modifications to the system and its operation. Discussion: The chemical EDS was validated for the treatment of biosafety levels 3 and 4 waste effluent using laboratory-prepared spore packets along with commercial biological indicators; however, several issues and lessons learned identified during the process of onboarding are also discussed, including bleach product source, method of validation, dechlorination, and treated waste disposal.","PeriodicalId":7962,"journal":{"name":"Applied Biosafety","volume":"13 1","pages":"23-32"},"PeriodicalIF":1.5,"publicationDate":"2020-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73521297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Applied Biosafety
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1